» Articles » PMID: 21525301

Dopamine Transport by the Serotonin Transporter: a Mechanistically Distinct Mode of Substrate Translocation

Overview
Journal J Neurosci
Specialty Neurology
Date 2011 Apr 29
PMID 21525301
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The serotonin transporter (SERT) is the principal mechanism for terminating serotonin (5-HT) signals in the nervous system and is a site of action for a variety of psychoactive drugs including antidepressants, amphetamines, and cocaine. Here we show that human SERTs (hSERTs) and rat SERTs are capable of robust dopamine (DA) uptake through a process that differs mechanistically from 5-HT transport in several unanticipated ways. DA transport by hSERT has a higher maximum velocity than 5-HT transport, requires significantly higher Na(+) and Cl(-) concentrations to sustain transport, is inhibited noncompetitively by 5-HT, and is more sensitive to SERT inhibitors, including selective serotonin reuptake inhibitors. We use a thiol-reactive methane thiosulfonate (MTS) reagent to modify a conformationally sensitive cysteine residue to demonstrate that hSERT spends more time in an outward facing conformation when transporting DA than when transporting 5-HT. Cotransfection of an inactive or an MTS-sensitive SERT with wild-type SERT subunits reveals an absence of cooperative interactions between subunits during DA but not 5-HT transport. To establish the physiological relevance of this mechanism for DA clearance, we show using in vivo high-speed chronoamperometry that SERT has the capacity to clear extracellularly applied DA in the hippocampal CA3 region of anesthetized rats. Together, these observations suggest the possibility that SERT serves as a DA transporter in vivo and highlight the idea that there can be distinct modes of transport of alternative physiological substrates by SERT.

Citing Articles

Fluorescent non-canonical amino acid provides insight into the human serotonin transporter.

Nygaard A, Zachariassen L, Larsen K, Kristensen A, Loland C Nat Commun. 2024; 15(1):9267.

PMID: 39463388 PMC: 11514162. DOI: 10.1038/s41467-024-53584-9.


The nucleus accumbens in reward and aversion processing: insights and implications.

Xu Y, Lin Y, Yu M, Zhou K Front Behav Neurosci. 2024; 18:1420028.

PMID: 39184934 PMC: 11341389. DOI: 10.3389/fnbeh.2024.1420028.


Oligomerization of Monoamine Transporters.

Paul A, Shukla D Subcell Biochem. 2024; 104:119-137.

PMID: 38963486 DOI: 10.1007/978-3-031-58843-3_7.


Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.

Chen Y, Kuo T, Wang V, Cheng P, Yi-Kung Huang E, Ma K J Parkinsons Dis. 2024; 14(5):941-964.

PMID: 38905058 PMC: 11307072. DOI: 10.3233/JPD-240080.


Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter.

Traktirov D, Nazarov I, Artemova V, Gainetdinov R, Pestereva N, Karpenko M Biomedicines. 2023; 11(11).

PMID: 38001881 PMC: 10669523. DOI: 10.3390/biomedicines11112881.


References
1.
Corey J, Quick M, Davidson N, Lester H, Guastella J . A cocaine-sensitive Drosophila serotonin transporter: cloning, expression, and electrophysiological characterization. Proc Natl Acad Sci U S A. 1994; 91(3):1188-92. PMC: 521479. DOI: 10.1073/pnas.91.3.1188. View

2.
Celik L, Sinning S, Severinsen K, Hansen C, Moller M, Bols M . Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation. J Am Chem Soc. 2008; 130(12):3853-65. DOI: 10.1021/ja076403h. View

3.
Zhou F, Liang Y, Salas R, Zhang L, De Biasi M, Dani J . Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron. 2005; 46(1):65-74. DOI: 10.1016/j.neuron.2005.02.010. View

4.
Kelly E, Jenner P, Marsden C . Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro. J Neurochem. 1985; 45(1):137-44. DOI: 10.1111/j.1471-4159.1985.tb05485.x. View

5.
Daws L . Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther. 2008; 121(1):89-99. PMC: 2739988. DOI: 10.1016/j.pharmthera.2008.10.004. View